Role of Ciliary Neurotrophic Factor in Angiotensin II-Induced Hypertension

Sebastian A Potthoff1, Ivo Quack1, Yuri Mori2

  • 1Department of Nephrology, Medical Faculty, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Germany (S.A.P., I.Q., D. Arifaj, M.K., D. Argov, L.C.R., J.S.).

PubMed

Insights

Ciliary neurotrophic factor (CNTF) plays a key role in regulating blood pressure by modulating angiotensin II-induced responses. This cytokine impacts hypertension through a JAK2/STAT3-dependent pathway, highlighting its significance in cardiovascular regulation.

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Molecular Medicine

Background:

  • Ciliary neurotrophic factor (CNTF), a member of the IL-6 cytokine family, is primarily recognized for its neuroprotective effects.
  • The influence of CNTF on vascular function and its role in hypertension remain largely unexplored.
  • This study investigates the role of CNTF in angiotensin II (AngII)-induced hypertension.

Purpose of the Study:

  • To elucidate the role of CNTF in the development and regulation of AngII-induced hypertension.
  • To examine the impact of CNTF on vascular responses to AngII.
  • To investigate the underlying molecular mechanisms, specifically the JAK2/STAT3 pathway, involved in CNTF's effects on blood pressure.

Main Methods:

  • Utilized CNTF-knockout and wild-type mice to study AngII-induced hypertension.
  • Measured blood pressure using tail-cuff and radiotelemetry methods.
  • Assessed vascular function, renal pressor responses, and JAK2/STAT3 pathway activation in vivo, ex vivo (isolated perfused kidney), and in vitro (vascular smooth muscle cells).

Main Results:

  • CNTF-knockout mice exhibited attenuated blood pressure increases and reduced hypertensive organ damage in response to AngII compared to wild-type mice.
  • The renal pressor response to AngII was significantly decreased in CNTF-knockout mice, and this effect was partially restored by acute CNTF administration.
  • CNTF was found to augment AngII-induced JAK2/STAT3 pathway activation in vascular smooth muscle cells, a mechanism crucial for its effect on blood pressure.

Conclusions:

  • CNTF significantly impacts blood pressure regulation by modulating the AngII-induced pressor response.
  • The observed effects of CNTF are mediated through a JAK2/STAT3-dependent mechanism.
  • CNTF emerges as a critical regulatory cytokine in the context of hypertension.
Abstract

Related Concept Videos

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
463
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
576
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
480
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
376
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
306